Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02320305
Brief Title: MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery

First Submitted : December 15, 2014
First Submitted that Met QC Criteria : December 15, 2014
First Posted : December 19, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : August 1, 2019
Last Update Posted : August 5, 2019